9th annual Next Generation Pharmaceutical Samples

October 16-17, 2019 | USA

CBI’s 9th annual Next Generation Pharmaceutical Samples returns as the preeminent forum to discuss best practices in physician sample programs. Benefit from compelling content that addresses the biggest emerging issues in sample programs and chart your program growth for 2019 and beyond. This year’s program will look closely at staff training, data priorities, analytics, audits & inspections, state level regulations, emerging technologies, the changing federal landscape and global sample programs.

Spotlight

More patients may seek advice on hay fever in the future since NHS England has advised GPs not to routinely prescribe products that are available over the counter for this condition.


OTHER PAST CONFERENCES

3rd International Pharmaceutical Conference and Expo

September 29-30, 2022 | UK

3rd International Pharmaceutical Conference and Expo welcome you as our guest to London, UK on September 29-30, 2022. i-Pharma 2022 includes nearly every permutation of knowledge, innovation, technology, and networking; and has the objective of creating an international forum for academicians,

REIMAGINING THE MEETING PLANNING EXPERIENCE IN LIFE SCIENCES

September 11-14, 2022 | USA

Pharma Forum is the largest, most influential conference for Meeting & Event Professionals to navigate the future of medical meetings, address compliance implications and execute contracting strategies with virtual, hybrid, and face-to-face.

DigIT Pharma Commercial Excellence & Digital Health

September 28-29, 2022 | Germany

Future of Pharma Business: New Pharma Business Unit Opportunities – Datengetriebene Business Itelligence und Commercial Excellence in Zeiten von DIGAs,

Pharma Manufacturing And Automation

November 15, 2022 | USA

Join over 300 senior representatives across two days of cutting-edge presentations on the biggest issues and opportunities in drug product manufacturing and digital transformation.

Spotlight

More patients may seek advice on hay fever in the future since NHS England has advised GPs not to routinely prescribe products that are available over the counter for this condition.

resources